Examining Sterile Compounding for Health-Systems: A Look Ahead to 2020

A discussion surrounding the finalized update to USP <797> and current understanding of USP <800> will ensure learners are up to date on necessary compliance elements for their health-systems.

Expert Answers: Sterile Compounding in Health Systems

Faculty will shed light on difficult concepts and common concerns related to the implementation of new sterile compounding regulations, while providing attendees with immediate feedback and reinforcement of key points.

Fertility Module #1: Fertility Care Considerations: Introduction to Infertility for the Specialty Health Care Pharmacist

Module 1 reviews the physiology of reproduction and the effects of hormone regulation. Also discussed are risk factors for infertility, diagnostic tests used in identifying infertility, and types of assisted reproductive technology. Available for free to NASP members. Visit www.ProCE.com/CSPE

Fertility Module #2: Infertility: Therapeutics and Medication Profiles

Module 2 will review the mechanism of action of the typical agents used to affect infertility. Medication adverse effects, administration, storage, and other information regarding these agents will also be discussed. Available for free to NASP members. Visit www.ProCE.com/CSPE

Fertility Module #3: Infertility: Protocols and Patient Management

Module 3 reviews the appropriate pharmacological and non-pharmacological protocols typically used to address infertility. Available for free to NASP members. Visit www.ProCE.com/CSPE

Fertility Module #4: Fertility Care Considerations: Infertility: Special Populations and Considerations

Module 4 will conclude with addressing some of the special considerations in patients with infertility issues. The role of the specialty pharmacy and the pharmacy care plan along with issues of adherence will also be discussed. Available for free to NASP members. Visit www.ProCE.com/CSPE

Going Forward in Reverse: Navigating Treatment for Acute Major Bleeding

The goal of this educational activity is to enhance the pharmacist’s knowledge of the impact of acute major bleeding and patient assessment and management options.

Hemophilia in Specialty Pharmacy

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #1: The abCs of HCV

Module One will address the epidemiology, diagnosis, and pathophysiology of HCV. Staging of HCV will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #2: Direct Acting Antivirals for the Treatment of Hepatitis C

Module Two will discuss the evolution of HCV treatments and the pharmacology of current agents. Possible drug interactions will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.